vs

Side-by-side financial comparison of ICON PLC (ICLR) and Inotiv, Inc. (NOTV). Click either name above to swap in a different company.

ICON PLC is the larger business by last-quarter revenue ($2.0B vs $120.9M, roughly 16.9× Inotiv, Inc.). ICON PLC runs the higher net margin — 0.1% vs -23.5%, a 23.6% gap on every dollar of revenue. On growth, Inotiv, Inc. posted the faster year-over-year revenue change (0.8% vs 0.6%). ICON PLC produced more free cash flow last quarter ($333.9M vs $-10.6M). Over the past eight quarters, Inotiv, Inc.'s revenue compounded faster (0.8% CAGR vs 0.6%).

ICON plc is an Irish headquartered multinational healthcare intelligence and clinical research organisation. As of February 2025 had approximately 41,900 employees in 55 countries.

Inotiv, Inc. is a contract research organization organized in Indiana and headquartered in Lafayette, Indiana. The company operates two core business units: Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). The CRS business unit offers drug development and environmental sciences services, including safety assessment, analytical, metabolism, CMC and regulatory consultancy for small molecule drug candidates, biotherapeutics, and biomedical devices. The RMS business u...

ICLR vs NOTV — Head-to-Head

Bigger by revenue
ICLR
ICLR
16.9× larger
ICLR
$2.0B
$120.9M
NOTV
Growing faster (revenue YoY)
NOTV
NOTV
+0.2% gap
NOTV
0.8%
0.6%
ICLR
Higher net margin
ICLR
ICLR
23.6% more per $
ICLR
0.1%
-23.5%
NOTV
More free cash flow
ICLR
ICLR
$344.5M more FCF
ICLR
$333.9M
$-10.6M
NOTV
Faster 2-yr revenue CAGR
NOTV
NOTV
Annualised
NOTV
0.8%
0.6%
ICLR

Income Statement — Q3 2025 vs Q1 2026

Metric
ICLR
ICLR
NOTV
NOTV
Revenue
$2.0B
$120.9M
Net Profit
$2.4M
$-28.4M
Gross Margin
Operating Margin
4.2%
-13.5%
Net Margin
0.1%
-23.5%
Revenue YoY
0.6%
0.8%
Net Profit YoY
-98.8%
-2.7%
EPS (diluted)
$0.03
$-0.83

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ICLR
ICLR
NOTV
NOTV
Q4 25
$120.9M
Q3 25
$2.0B
$138.1M
Q2 25
$2.0B
$130.7M
Q1 25
$2.0B
$124.3M
Q4 24
$119.9M
Q3 24
$2.0B
$130.4M
Q2 24
$2.1B
$105.8M
Q1 24
$2.1B
$119.0M
Net Profit
ICLR
ICLR
NOTV
NOTV
Q4 25
$-28.4M
Q3 25
$2.4M
$-8.6M
Q2 25
$183.0M
$-17.6M
Q1 25
$154.2M
$-14.9M
Q4 24
$-27.6M
Q3 24
$197.1M
$-18.9M
Q2 24
$146.9M
$-26.1M
Q1 24
$187.4M
$-48.1M
Operating Margin
ICLR
ICLR
NOTV
NOTV
Q4 25
-13.5%
Q3 25
4.2%
-4.9%
Q2 25
10.4%
-4.3%
Q1 25
11.0%
-2.4%
Q4 24
-12.9%
Q3 24
14.1%
-10.1%
Q2 24
10.8%
-19.6%
Q1 24
13.7%
-36.2%
Net Margin
ICLR
ICLR
NOTV
NOTV
Q4 25
-23.5%
Q3 25
0.1%
-6.2%
Q2 25
9.1%
-13.5%
Q1 25
7.7%
-12.0%
Q4 24
-23.0%
Q3 24
9.7%
-14.5%
Q2 24
6.9%
-24.7%
Q1 24
9.0%
-40.4%
EPS (diluted)
ICLR
ICLR
NOTV
NOTV
Q4 25
$-0.83
Q3 25
$0.03
$-0.14
Q2 25
$2.30
$-0.51
Q1 25
$1.90
$-0.44
Q4 24
$-1.02
Q3 24
$2.36
$-0.73
Q2 24
$1.76
$-1.00
Q1 24
$2.25
$-1.86

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ICLR
ICLR
NOTV
NOTV
Cash + ST InvestmentsLiquidity on hand
$468.9M
$12.7M
Total DebtLower is stronger
$405.8M
Stockholders' EquityBook value
$9.3B
$109.0M
Total Assets
$16.5B
$734.3M
Debt / EquityLower = less leverage
3.72×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ICLR
ICLR
NOTV
NOTV
Q4 25
$12.7M
Q3 25
$468.9M
$21.7M
Q2 25
$390.4M
$6.2M
Q1 25
$526.7M
$19.3M
Q4 24
$38.0M
Q3 24
$695.5M
$21.4M
Q2 24
$506.6M
$14.4M
Q1 24
$396.1M
$32.7M
Total Debt
ICLR
ICLR
NOTV
NOTV
Q4 25
$405.8M
Q3 25
$402.1M
Q2 25
$396.5M
Q1 25
$399.5M
Q4 24
$396.0M
Q3 24
$393.3M
Q2 24
$382.4M
Q1 24
$380.6M
Stockholders' Equity
ICLR
ICLR
NOTV
NOTV
Q4 25
$109.0M
Q3 25
$9.3B
$136.0M
Q2 25
$9.6B
$143.8M
Q1 25
$9.5B
$157.7M
Q4 24
$169.8M
Q3 24
$9.8B
$170.5M
Q2 24
$9.6B
$182.1M
Q1 24
$9.4B
$207.2M
Total Assets
ICLR
ICLR
NOTV
NOTV
Q4 25
$734.3M
Q3 25
$16.5B
$771.1M
Q2 25
$16.6B
$759.7M
Q1 25
$16.7B
$766.0M
Q4 24
$772.9M
Q3 24
$17.2B
$781.4M
Q2 24
$17.0B
$774.6M
Q1 24
$17.0B
$815.4M
Debt / Equity
ICLR
ICLR
NOTV
NOTV
Q4 25
3.72×
Q3 25
2.96×
Q2 25
2.76×
Q1 25
2.53×
Q4 24
2.33×
Q3 24
2.31×
Q2 24
2.10×
Q1 24
1.84×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ICLR
ICLR
NOTV
NOTV
Operating Cash FlowLast quarter
$387.6M
$-5.4M
Free Cash FlowOCF − Capex
$333.9M
$-10.6M
FCF MarginFCF / Revenue
16.3%
-8.8%
Capex IntensityCapex / Revenue
2.6%
4.3%
Cash ConversionOCF / Net Profit
164.59×
TTM Free Cash FlowTrailing 4 quarters
$1.0B
$-28.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ICLR
ICLR
NOTV
NOTV
Q4 25
$-5.4M
Q3 25
$387.6M
$14.3M
Q2 25
$146.2M
$-7.4M
Q1 25
$268.2M
$-12.8M
Q4 24
$-4.5M
Q3 24
$402.7M
$-2.4M
Q2 24
$218.6M
$-14.8M
Q1 24
$327.1M
$16.9M
Free Cash Flow
ICLR
ICLR
NOTV
NOTV
Q4 25
$-10.6M
Q3 25
$333.9M
$11.6M
Q2 25
$113.9M
$-11.5M
Q1 25
$239.3M
$-18.3M
Q4 24
$-9.0M
Q3 24
$359.3M
$-7.7M
Q2 24
$182.3M
$-19.2M
Q1 24
$299.9M
$9.9M
FCF Margin
ICLR
ICLR
NOTV
NOTV
Q4 25
-8.8%
Q3 25
16.3%
8.4%
Q2 25
5.6%
-8.8%
Q1 25
12.0%
-14.7%
Q4 24
-7.5%
Q3 24
17.7%
-5.9%
Q2 24
8.6%
-18.2%
Q1 24
14.3%
8.3%
Capex Intensity
ICLR
ICLR
NOTV
NOTV
Q4 25
4.3%
Q3 25
2.6%
1.9%
Q2 25
1.6%
3.1%
Q1 25
1.4%
4.4%
Q4 24
3.7%
Q3 24
2.1%
4.1%
Q2 24
1.7%
4.2%
Q1 24
1.3%
5.9%
Cash Conversion
ICLR
ICLR
NOTV
NOTV
Q4 25
Q3 25
164.59×
Q2 25
0.80×
Q1 25
1.74×
Q4 24
Q3 24
2.04×
Q2 24
1.49×
Q1 24
1.74×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ICLR
ICLR

Other Customers$681.3M33%
Clients1125$549.4M27%
Clients15$503.3M25%
Clients610$308.8M15%

NOTV
NOTV

Research Models And Services Segment$72.9M60%
Discovery And Safety Assessment Segment$48.0M40%

Related Comparisons